Produkty lecznicze - Wykaz pozwoleń na dopuszczenie do obrotu udzielonych przez państwa EFTA należące do EOG w pierwszym półroczu 2018 r.
Dz.U.UE.C.2019.68.5
Akt nieocenianyProdukty lecznicze - Wykaz pozwoleń na dopuszczenie do obrotu udzielonych przez państwa EFTA należące do EOG w pierwszym półroczu 2018 r.
(Dz.U.UE C z dnia 21 lutego 2019 r.)
Podkomitet I ds. swobodnego przepływu towarów
Do wiadomości Wspólnego Komitetu EOG
W nawiązaniu do decyzji Wspólnego Komitetu EOG nr 74/1999 z dnia 28 maja 1999 r. Wspólnemu Komitetowi EOG przekazuje się celem przyjęcia do wiadomości na posiedzeniu w dniu 26 października 2018 r. następujące wykazy dotyczące pozwoleń na dopuszczenie do obrotu produktów leczniczych za okres od dnia 1 stycznia do dnia 30 czerwca 2018 r.:
ZAŁĄCZNIK I Wykaz nowych pozwoleń na dopuszczenie do obrotu
ZAŁĄCZNIK II Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
ZAŁĄCZNIK III Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
ZAŁĄCZNIK IV Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
ZAŁĄCZNIK V Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
ZAŁĄCZNIKI
ZAŁĄCZNIK I
Wykaz nowych pozwoleń na dopuszczenie do obrotu
Wykaz nowych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data udzielenia pozwolenia | |
UE/1/13/901 | Sirturo | Liechtenstein | 30.4.2018 | |
UE/1/15/1047 | Blincyto | Liechtenstein | 30.6.2018 | |
UE/1/17/1173 | Lokelma | Islandia | 26.3.2018 | |
UE/1/17/1173 | Lokelma | Liechtenstein | 30.4.2018 | |
UE/1/17/1173 | Lokelma | Norwegia | 16.4.2018 | |
UE/1/17/1231 | Ocrevus | Islandia | 11.1.2018 | |
UE/1/17/1231 | Ocrevus | Liechtenstein | 28.2.2018 | |
UE/1/17/1231 | Ocrevus | Norwegia | 17.1.2018 | |
UE/1/17/1234 | Tremfya | Norwegia | 18.1.2018 | |
UE/1/17/1244 | Tacforius | Islandia | 5.1.2018 | |
UE/1/17/1244 | Tacforius | Norwegia | 3.1.2018 | |
UE/1/17/1245 | Prevymis | Islandia | 19.1.2018 | |
UE/1/17/1245 | PREVYMIS | Liechtenstein | 28.2.2018 | |
UE/1/17/1245 | PREVYMIS | Norwegia | 5.2.2018 | |
UE/1/17/1246 | Mvasi | Islandia | 24.1.2018 | |
UE/1/17/1246 | Mvasi | Norwegia | 30.1.2018 | |
UE/1/17/1247 | Adynovi | Islandia | 11.1.2018 | |
UE/1/17/1247 | ADYNOVI | Liechtenstein | 28.2.2018 | |
UE/1/17/1247 | ADYNOVI | Norwegia | 19.1.2018 | |
UE/1/17/1248 | Darunavir Krka d.d. | Islandia | 24.1.2018 | |
UE/1/17/1248 | Darunavir Krka d.d. | Norwegia | 14.2.2018 | |
UE/1/17/1249 | Darunavir Krka | Islandia | 26.1.2018 | |
UE/1/17/1249 | Darunavir Krka | Liechtenstein | 28.2.2018 | |
UE/1/17/1249 | Darunavir Krka | Norwegia | 14.2.2018 | |
UE/1/17/1250 | Rubraca | Islandia | 5.6.2018 | |
UE/1/17/1250 | Rubraca | Liechtenstein | 30.6.2018 | |
UE/1/17/1250 | Rubraca | Norwegia | 31.5.2018 | |
UE/1/17/1251 | Ozempic | Islandia | 15.2.2018 | |
UE/1/17/1251 | Ozempic | Liechtenstein | 28.2.2018 | |
UE/1/17/1251 | Ozempic | Norwegia | 14.2.2018 | |
UE/1/17/1252 | Fasenra | Islandia | 11.1.2018 | |
UE/1/17/1252 | Fasenra | Liechtenstein | 28.2.2018 | |
UE/1/17/1252 | Fasenra | Norwegia | 16.1.2018 | |
UE/1/17/1253 | Fulvestrant Mylan | Islandia | 12.2.2018 | |
UE/1/17/1253 | Fulvestrant Mylan | Liechtenstein | 28.2.2018 | |
UE/1/17/1253 | Fulvestrant Mylan | Norwegia | 29.5.2018 | |
UE/1/17/1254 | Jorveza | Islandia | 15.1.2018 | |
UE/1/17/1254 | Jorveza | Liechtenstein | 28.2.2018 | |
UE/1/17/1254 | Jorveza | Norwegia | 19.1.2018 | |
UE/1/17/1255 | Intrarosa | Islandia | 7.2.2018 | |
UE/1/17/1255 | Intrarosa | Liechtenstein | 28.2.2018 | |
UE/1/17/1256 | Anagrelide Mylan | Islandia | 26.2.2018 | |
UE/1/17/1256 | Anagrelide Mylan | Liechtenstein | 28.2.2018 | |
UE/1/17/1256 | Anagrelide Mylan | Norwegia | 27.2.2018 | |
UE/1/17/1257 | Herzuma | Islandia | 15.2.2018 | |
UE/1/17/1257 | Herzuma | Liechtenstein | 28.2.2018 | |
UE/1/17/1257 | Herzuma | Norwegia | 14.2.2018 | |
UE/1/17/1258 | Lamzede | Islandia | 11.4.2018 | |
UE/1/17/1258 | Lamzede | Liechtenstein | 30.4.2018 | |
UE/1/17/1258 | Lamzede | Norwegia | 16.4.2018 | |
UE/1/17/1260 | Alkindi | Islandia | 15.2.2018 | |
UE/1/17/1260 | Alkindi | Liechtenstein | 28.2.2018 | |
UE/1/17/1260 | Alkindi | Norwegia | 2.3.2018 | |
UE/1/17/1261 | Alofisel | Islandia | 10.4.2018 | |
UE/1/17/1261 | Alofisel | Liechtenstein | 30.4.2018 | |
UE/1/17/1261 | Alofisel | Norwegia | 9.4.2018 | |
UE/1/17/1262 | Crysvita | Islandia | 26.2.2018 | |
UE/1/17/1262 | CRYSVITA | Liechtenstein | 30.4.2018 | |
UE/1/17/1262 | CRYSVITA | Norwegia | 9.4.2018 | |
UE/1/17/1263 | Efavirenz/Emtricitabine/Tenofovir disoproxil Krka | Islandia | 15.2.2018 | |
UE/1/17/1263 | Efavirenz/Emtricitabine/Tenofovir disoproxil Krka | Liechtenstein | 28.2.2018 | |
UE/1/17/1263 | Efavirenz/Emtricitabine/Tenofovir disoproxil Krka | Norwegia | 14.2.2018 | |
UE/1/18/1265 | Segluromet | Islandia | 10.4.2018 | |
UE/1/18/1265 | Segluromet | Liechtenstein | 30.4.2018 | |
UE/1/18/1265 | Segluromet | Norwegia | 9.4.2018 | |
UE/1/18/1266 | Steglujan | Islandia | 11.4.2018 | |
UE/1/18/1266 | Steglujan | Liechtenstein | 30.4.2018 | |
UE/1/18/1266 | Steglujan | Norwegia | 7.4.2018 | |
UE/1/18/1267 | Steglatro | Islandia | 10.4.2018 | |
UE/1/18/1267 | Steglatro | Liechtenstein | 30.4.2018 | |
UE/1/18/1267 | Stegatro | Norwegia | 9.4.2018 | |
UE/1/18/1269 | Alpivab | Islandia | 11.5.2018 | |
UE/1/18/1269 | Alpivab | Liechtenstein | 30.4.2018 | |
UE/1/18/1269 | Alpivab | Norwegia | 26.6.2018 | |
UE/1/18/1270 | Semglee | Islandia | 10.4.2018 | |
UE/1/18/1270 | Semglee | Liechtenstein | 30.4.2018 | |
UE/1/18/1270 | Semglee | Norwegia | 23.5.2018 | |
UE/1/18/1271 | Hemlibra | Islandia | 2.3.2018 | |
UE/1/18/1271 | Hemlibra | Liechtenstein | 28.2.2018 | |
UE/1/18/1271 | Hemlibra | Norwegia | 8.3.2018 | |
UE/1/18/1272 | Shingrix | Islandia | 26.3.2018 | |
UE/1/18/1272 | Shingrix | Liechtenstein | 30.4.2018 | |
UE/1/18/1272 | Shingrix | Norwegia | 5.4.2018 | |
UE/1/18/1273 | Prasugrel Mylan | Islandia | 29.5.2018 | |
UE/1/18/1273 | Prasugrel Mylan | Liechtenstein | 30.6.2018 | |
UE/1/18/1274 | Trydonis | Islandia | 23.5.2018 | |
UE/1/18/1274 | Trydonis | Liechtenstein | 30.6.2018 | |
UE/1/18/1274 | Trydonis | Norwegia | 28.5.2018 | |
UE/1/18/1275 | Riarify | Islandia | 23.5.2018 | |
UE/1/18/1275 | Riarify | Liechtenstein | 30.6.2018 | |
UE/1/18/1277 | Mylotarg | Islandia | 16.5.2018 | |
UE/1/18/1277 | Mylotarg | Liechtenstein | 30.6.2018 | |
UE/1/18/1277 | Mylotarg | Norwegia | 4.5.2018 | |
UE/1/18/1279 | AMGLIDIA | Islandia | 5.6.2018 | |
UE/1/18/1279 | AMGLIDIA | Liechtenstein | 30.6.2018 | |
UE/1/18/1279 | AMGLIDIA | Norwegia | 26.6.2018 | |
UE/1/18/1280 | Zessly | Islandia | 4.6.2018 | |
UE/1/18/1280 | Zessly | Liechtenstein | 30.6.2018 | |
UE/1/18/1280 | Zessly | Norwegia | 15.6.2018 | |
UE/1/18/1281 | Kanjinti | Islandia | 29.5.2018 | |
UE/1/18/1281 | KANJINTI | Liechtenstein | 30.6.2018 | |
UE/1/18/1281 | KANJINTI | Norwegia | 24.5.2018 | |
UE/1/18/1282 | Juluca | Islandia | 29.5.2018 | |
UE/1/18/1282 | Juluca | Liechtenstein | 30.6.2018 | |
UE/1/18/1282 | Juluca | Norwegia | 24.5.2018 | |
UE/1/18/1283 | Pemetrexed Krka | Islandia | 30.5.2018 | |
UE/1/18/1283 | Pemetrexed Krka | Liechtenstein | 30.6.2018 | |
UE/1/18/1283 | Pemetrexed Krka | Norwegia | 31.5.2018 | |
UE/1/18/1289 | Biktarvy | Islandia | 28.6.2018 | |
UE/1/18/1289 | Bictarvy | Liechtenstein | 30.6.2018 | |
UE/1/18/1289 | Biktarvy | Norwegia | 27.6.2018 | |
UE/2/17/216 | Oxybee | Islandia | 26.3.2018 | |
UE/2/17/216 | Oxybee | Liechtenstein | 30.4.2018 | |
UE/2/17/216 | Oxybee | Norwegia | 20.4.2018 | |
UE/2/17/219 | Rabitec | Islandia | 4.1.2018 | |
UE/2/17/219 | Rabitec | Liechtenstein | 28.2.2018 | |
UE/2/17/219 | Rabitec | Norwegia | 9.1.2018 | |
UE/2/17/220 | MiPet Easecto | Islandia | 26.2.2018 | |
UE/2/17/220 | MiPet Easecto | Norwegia | 20.4.2018 | |
UE/2/17/221 | GALLIPRANT | Islandia | 17.1.2018 | |
UE/2/17/221 | GALLIPRANT | Liechtenstein | 28.2.2018 | |
UE/2/17/221 | GALLIPRANT | Norwegia | 24.1.2018 | |
UE/2/17/222 | Clevor | Islandia | 3.5.2018 | |
UE/2/17/222 | Clevor | Liechtenstein | 30.4.2018 | |
UE/2/17/222 | Clevor | Norwegia | 7.5.2018 | |
UE/2/17/223 | Suvaxyn Circo | Islandia | 12.4.2018 | |
UE/1/17/223 | Suvaxyn Circo | Liechtenstein | 28.2.2018 | |
UE/2/17/223 | Suvaxyn Circo | Norwegia | 13.2.2018 | |
UE/2/18/224 | Bravecto Plus | Islandia | 28.5.2018 | |
UE/2/18/224 | Bravecto Plus | Liechtenstein | 30.6.2018 | |
UE/2/18/224 | Bravecto Plus | Norwegia | 1.6.2018 | |
UE/2/18/225 | Dany's BienenWohl | Islandia | 21.6.2018 | |
UE/2/18/225 | Dany's BienenWohl | Liechtenstein | 30.6.2018 | |
UE/2/18/225 | Dany's BienenWohl | Norwegia | 29.6.2018 |
ZAŁĄCZNIK II
Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
Wykaz odnowionych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data udzielenia pozwolenia |
UE/1/08/442 | Pradaxa | Islandia | 12.1.2018 |
UE/1/08/442 | Pradaxa | Liechtenstein | 28.2.2018 |
UE/1/08/442 | Pradaxa | Norwegia | 18.1.2018 |
UE/1/08/443 | Thalidomide Celgene | Islandia | 14.2.2018 |
UE/1/08/443 | Thalidomide Celgene | Liechtenstein | 28.2.2018 |
UE/1/08/443 | Thalidomide Celgene | Norwegia | 6.3.2018 |
UE/1/08/448 | Mycamine | Islandia | 26.2.2018 |
UE/1/08/472 | Xarelto | Islandia | 30.5.2018 |
UE/1/08/472 | Xarelto | Liechtenstein | 30.6.2018 |
UE/1/08/472 | Xarelto | Norwegia | 21.6.2018 |
UE/1/10/628 | Votrient | Islandia | 18.1.2018 |
UE/1/10/628 | Votrient | Liechtenstein | 28.2.2018 |
UE/1/10/628 | Votrient | Norwegia | 17.1.2018 |
UE/1/11/749 | Caprelsa | Islandia | 15.2.2018 |
UE/1/11/749 | Caprelsa | Liechtenstein | 28.2.2018 |
UE/1/11/749 | Caprelsa | Norwegia | 15.2.2018 |
UE/1/12/764 | Pixuvri | Islandia | 11.4.2018 |
UE/1/12/764 | Pixuvri | Liechtenstein | 30.4.2018 |
UE/1/12/764 | Pixuvri | Norwegia | 4.4.2018 |
UE/1/13/813 | Perjeta | Norwegia | 3.1.2018 |
UE/1/13/817 | Actelsar HCT | Islandia | 5.1.2018 |
UE/1/13/817 | Actelsar HCT | Norwegia | 4.1.2018 |
UE/1/13/818 | Bosulif | Islandia | 26.2.2018 |
UE/1/13/818 | Bosulif | Liechtenstein | 28.2.2018 |
UE/1/13/818 | Bosulif | Norwegia | 21.2.2018 |
UE/1/13/820 | Marixino | Islandia | 24.1.2018 |
UE/1/13/820 | Marixino | Liechtenstein | 28.2.2018 |
UE/1/13/820 | Marixino | Norwegia | 14.2.2018 |
UE/1/13/821 | Tolucombi | Islandia | 29.1.2018 |
UE/1/13/821 | Tolucombi | Norwegia | 20.3.2018 |
UE/1/13/822 | PHEBURANE | Islandia | 10.4.2018 |
UE/1/13/822 | PHEBURANE | Liechtenstein | 30.4.2018 |
UE/1/13/822 | PHEBURANE | Norwegia | 16.4.2018 |
UE/1/13/823 | Adasuve | Islandia | 24.1.2018 |
UE/1/13/823 | Adasuve | Norwegia | 16.3.2018 |
UE/1/13/824 | Nemdatine | Islandia | 29.1.2018 |
UE/1/13/825 | Imatinib Actavis | Islandia | 12.1.2018 |
UE/1/13/825 | Imatinib Actavis | Liechtenstein | 28.2.2018 |
UE/1/13/825 | Imatinib Actavis | Norwegia | 12.1.2018 |
UE/1/13/826 | Memantine LEK | Islandia | 29.1.2018 |
UE/1/13/827 | Memantine Mylan | Islandia | 29.1.2018 |
UE/1/13/828 | Hexacima | Islandia | 29.1.2018 |
UE/1/13/829 | Hexyon | Islandia | 29.1.2018 |
UE/1/13/829 | Hexyon | Liechtenstein | 30.6.2018 |
UE/1/13/829 | Hexyon | Norwegia | 12.2.2018 |
UE/1/13/830 | Stribild | Islandia | 16.5.2018 |
UE/1/13/830 | Stribild | Norwegia | 7.5.2018 |
UE/1/13/832 | Stayveer | Islandia | 24.1.2018 |
UE/1/13/832 | Stayveer | Liechtenstein | 28.2.2018 |
UE/1/13/832 | Stayveer | Norwegia | 24.1.2018 |
UE/1/13/835 | Voriconazole Accord | Islandia | 14.2.2018 |
UE/1/13/835 | Voriconazole Accord | Liechtenstein | 28.2.2018 |
UE/1/13/835 | Voriconazole Accord | Norwegia | 2.3.2018 |
UE/1/13/836 | Memantine ratiopharm | Islandia | 3.5.2018 |
UE/1/13/836 | Memantine ratiopharm | Liechtenstein | 30.4.2018 |
UE/1/13/836 | Memantine ratiopharm | Norwegia | 7.5.2018 |
UE/1/13/838 | AUBAGIO | Islandia | 15.6.2018 |
UE/1/13/838 | AUBAGIO | Liechtenstein | 30.6.2018 |
UE/1/13/838 | AUBAGIO | Norwegia | 21.6.2018 |
UE/1/13/839 | Iclusig | Islandia | 23.2.2018 |
UE/1/13/839 | Iclusig | Liechtenstein | 28.2.2018 |
UE/1/13/839 | Iclusig | Norwegia | 20.2.2018 |
UE/1/13/840 | HyQvia | Islandia | 18.1.2018 |
UE/1/13/840 | HyQvia | Liechtenstein | 28.2.2018 |
UE/1/13/840 | HyQvia | Norwegia | 16.1.2018 |
UE/1/13/841 | Spedra | Islandia | 22.5.2018 |
UE/1/13/841 | Spedra | Liechtenstein | 30.6.2018 |
UE/1/13/841 | Spedra | Norwegia | 15.5.2018 |
UE/1/13/842 | Incresync | Islandia | 15.6.2018 |
UE/1/13/842 | Incresync | Liechtenstein | 30.6.2018 |
UE/1/13/843 | Vipdomet | Islandia | 15.6.2018 |
UE/1/13/843 | Vipdomet | Liechtenstein | 30.6.2018 |
UE/1/13/844 | Vipidia | Islandia | 15.6.2018 |
UE/1/13/844 | Vipidia | Liechtenstein | 30.6.2018 |
UE/1/13/844 | Vipidia | Norwegia | 26.6.2018 |
UE/1/13/845 | Imatinib Accord | Islandia | 16.5.2018 |
UE/1/13/845 | Imatinib Accord | Liechtenstein | 30.6.2018 |
UE/1/13/845 | Imatinib Accord | Norwegia | 4.5.2018 |
UE/1/13/846 | Xtandi | Islandia | 23.2.2018 |
UE/1/13/846 | Xtandi | Liechtenstein | 28.2.2018 |
UE/1/13/846 | Xtandi | Norwegia | 2.3.2018 |
UE/1/13/851 | Lojuxta | Islandia | 22.5.2018 |
UE/1/13/851 | Lojuxta | Liechtenstein | 30.6.2018 |
UE/1/13/851 | Lojuxta | Norwegia | 23.5.2018 |
UE/1/13/852 | Atosiban SUN | Islandia | 15.6.2018 |
UE/1/13/852 | Atosiban SUN | Liechtenstein | 30.6.2018 |
UE/1/13/852 | Atosiban SUN | Norwegia | 25.6.2018 |
UE/1/13/853 | Remsima | Islandia | 29.6.2018 |
UE/1/13/853 | Remsima | Liechtenstein | 30.6.2018 |
UE/1/13/854 | Inflectra | Islandia | 28.6.2018 |
UE/1/13/854 | Inflectra | Liechtenstein | 30.6.2018 |
UE/1/13/855 | IMVANEX | Islandia | 22.5.2018 |
UE/1/13/855 | IMVANEX | Liechtenstein | 30.6.2018 |
UE/1/13/855 | IMVANEX | Norwegia | 15.5.2018 |
UE/1/13/856 | Lonquex | Islandia | 25.5.2018 |
UE/1/13/856 | Lonquex | Liechtenstein | 30.6.2018 |
UE/1/13/856 | Lonquex | Norwegia | 25.5.2018 |
UE/1/13/857 | Voncento | Islandia | 23.5.2018 |
UE/1/13/857 | Voncento | Liechtenstein | 30.6.2018 |
UE/1/13/857 | Voncento | Norwegia | 23.5.2018 |
UE/1/13/858 | Stivarga | Islandia | 30.5.2018 |
UE/1/13/858 | Stivarga | Liechtenstein | 30.6.2018 |
UE/1/13/858 | Stivarga | Norwegia | 31.5.2018 |
UE/1/13/862 | Ultibro Breezhaler | Islandia | 30.5.2018 |
UE/1/13/862 | Ultibro Breezhaler | Liechtenstein | 30.6.2018 |
UE/1/13/862 | Ultibro Breezhaler | Norwegia | 21.6.2018 |
UE/1/13/863 | Xoterna Breezhaler | Islandia | 30.5.2018 |
UE/1/13/863 | Xoterna Breezhaler | Liechtenstein | 30.6.2018 |
UE/1/13/863 | Xoterna Breezhaler | Norwegia | 21.6.2018 |
UE/1/13/865 | Tafinlar | Islandia | 28.5.2018 |
UE/1/13/865 | Tafinlar | Liechtenstein | 30.6.2018 |
UE/1/13/865 | Tafinlar | Norwegia | 18.5.2018 |
UE/1/13/866 | Cholib | Islandia | 15.6.2018 |
UE/1/13/866 | Cholib | Liechtenstein | 30.6.2018 |
UE/1/13/866 | Cholib | Norwegia | 16.5.2018 |
UE/1/13/871 | Ovaleap | Islandia | 29.5.2018 |
UE/1/13/871 | Ovaleap | Liechtenstein | 30.6.2018 |
UE/1/13/871 | Ovaleap | Norwegia | 16.5.2018 |
UE/1/13/873 | Xofigo | Islandia | 29.6.2018 |
UE/1/13/873 | Xofigo | Liechtenstein | 30.6.2018 |
UE/1/13/875 | Deltyba | Islandia | 16.5.2018 |
UE/1/13/875 | Deltyba | Liechtenstein | 30.6.2018 |
UE/1/13/875 | Deltyba | Norwegia | 16.5.2018 |
UE/1/13/876 | Imatinib medac | Islandia | 16.5.2018 |
UE/1/13/876 | Imatinib Medac | Liechtenstein | 30.6.2018 |
UE/1/13/876 | Imatinib medac | Norwegia | 4.5.2018 |
UE/1/13/879 | Giotrif | Islandia | 29.5.2018 |
UE/1/13/879 | Giotrif | Liechtenstein | 30.6.2018 |
UE/1/13/879 | Giotrif | Norwegia | 24.5.2018 |
UE/1/13/890 | Cometriq | Islandia | 18.1.2018 |
UE/1/13/890 | Cometriq | Liechtenstein | 30.4.2018 |
UE/1/13/890 | Cometriq | Norwegia | 17.1.2018 |
UE/1/13/901 | Sirturo | Islandia | 14.3.2018 |
UE/1/13/901 | Sirturo | Norwegia | 22.3.2018 |
UE/1/14/987 | Holoclar | Norwegia | 4.1.2018 |
UE/1/15/1047 | Blincyto | Islandia | 16.5.2018 |
UE/1/15/1047 | Blincyto | Norwegia | 26.6.2018 |
UE/1/15/1078 | Natpar | Islandia | 16.5.2018 |
UE/1/15/1078 | Natpar | Liechtenstein | 30.6.2018 |
UE/1/16/1089 | Pandemiczna szczepionka przeciw grypie H5N1 AstraZeneca | Islandia | 12.4.2018 |
UE/1/16/1089 | Pandemiczna szczepionka przeciw grypie H5N1 AstraZeneca | Liechtenstein | 30.4.2018 |
UE/1/16/1089 | Pandemiczna szczepionka przeciw grypie H5N1 | Norwegia | 10.4.2018 |
UE/2/12/145 | Kexxtone | Islandia | 4.1.2018 |
UE/2/12/146 | Semintra | Islandia | 22.1.2018 |
UE/2/12/146 | Semintra | Liechtenstein | 28.2.2018 |
UE/2/12/146 | Semintra | Norwegia | 30.1.2018 |
UE/2/13/148 | Meloxidolor | Islandia | 16.5.2018 |
UE/2/13/148 | Meloxidolor | Liechtenstein | 30.6.2018 |
UE/2/13/148 | Meloxidolor | Norwegia | 16.5.2018 |
UE/2/13/149 | ECOPORC SHIGA | Islandia | 13.4.2018 |
UE/2/13/149 | ECOPORC SHIGA | Liechtenstein | 30.4.2018 |
UE/2/13/149 | ECOPORC SHIGA | Norwegia | 20.4.2018 |
UE/2/13/150 | Oncept IL-2 | Islandia | 26.3.2018 |
UE/2/13/150 | Oncept IL-2 | Liechtenstein | 30.4.2018 |
UE/2/13/150 | Oncept IL-2 | Norwegia | 19.4.2018 |
UE/2/13/151 | Equilis West Nile | Islandia | 15.5.2018 |
UE/2/13/151 | Equilis West Nile | Liechtenstein | 30.4.2018 |
UE/2/13/151 | Equilis West Nile | Norwegia | 7.5.2018 |
UE/2/13/152 | ProZinc | Islandia | 3.5.2018 |
UE/2/13/152 | ProZinc | Liechtenstein | 30.4.2018 |
UE/2/13/152 | ProZinc | Norwegia | 7.5.2018 |
UE/2/13/153 | Aftovaxpur Doe | Islandia | 21.6.2018 |
UE/2/13/153 | Aftovaxpur Doe | Liechtenstein | 30.6.2018 |
UE/2/13/153 | Aftovaxpur Doe | Norwegia | 28.6.2018 |
ZAŁĄCZNIK III
Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
Wykaz przedłużonych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data udzielenia pozwolenia | |
UE/1/10/636/008 | Daxas | Islandia | 22.5.2018 | |
UE/1/10/636/008 | Daxas | Norwegia | 23.4.2018 | |
UE/1/11/700/003-007 | Benlysta | Islandia | 10.1.2018 | |
UE/1/11/700/003-007 | Benlysta | Norwegia | 22.1.2018 | |
UE/1/11/710/016 | Votubia | Islandia | 18.6.2018 | |
UE/1/11/710/016 | Votubia | Norwegia | 8.6.2018 | |
UE/1/13/818/006-007 | Bosulif | Islandia | 30.5.2018 | |
UE/1/13/818/006-007 | Bosulif | Norwegia | 29.5.2018 | |
UE/1/14/936/005-007 | Nuwiq | Islandia | 11.4.2018 | |
UE/1/14/936/005-007 | Nuwiq | Norwegia | 20.4.2018 | |
UE/1/14/945/003-006 | IMBRUVICA | Norwegia | 29.6.2018 | |
UE/1/14/959/002-005 | Lynparza | Islandia | 24.5.2018 | |
UE/1/14/959/002-005 | Lynparza | Norwegia | 8.5.2018 | |
UE/1/15/1019/002 | Bortezomib Accord | Islandia | 18.6.2018 | |
UE/1/15/1019/002 | Bortezomib Accord | Norwegia | 14.6.2018 | |
UE/1/15/1059/005 | Orkambi | Islandia | 18.1.2018 | |
UE/1/15/1059/005 | Orkambi | Norwegia | 17.1.2018 | |
UE/1/15/1070/002 | Oncaspar | Norwegia | 3.1.2018 | |
UE/2/12/146/003 | Semintra | Islandia | 25.5.2018 | |
UE/2/12/146/003 | Semintra | Norwegia | 24.5.2018 |
ZAŁĄCZNIK IV
Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
Wykaz wycofanych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data wycofania |
UE/1/04/289 | Angiox | Liechtenstein | 30.6.2018 |
UE/1/06/368 | Insulin Human Winthrop | Islandia | 17.1.2018 |
UE/1/06/368 | Insulin Human Winthrop | Liechtenstein | 30.4.2018 |
UE/1/06/368 | Insulin Human Winthrop | Norwegia | 22.1.2018 |
UE/1/07/394 | Optaflu | Islandia | 12.2.2018 |
UE/1/08/507 | Idflu | Islandia | 11.4.2018 |
UE/1/08/507 | IDflu | Liechtenstein | 30.4.2018 |
UE/1/08/507 | IDflu | Norwegia | 5.4.2018 |
UE/1/11/705 | Vibativ | Islandia | 11.4.2018 |
UE/1/11/705 | Vibativ | Norwegia | 6.4.2018 |
UE/1/11/666 | Libertek | Islandia | 17.1.2018 |
UE/1/11/666 | Libertek | Liechtenstein | 28.2.2018 |
UE/1/11/666 | Libertek | Norwegia | 22.1.2018 |
UE/1/11/668 | Daliresp | Islandia | 17.1.2018 |
UE/1/11/668 | Daliresp | Liechtenstein | 28.2.2018 |
UE/1/11/668 | Daliresp | Norwegia | 22.1.2018 |
UE/1/12/772 | Zoledronic acid Teva Pharma | Islandia | 7.2.2018 |
UE/1/12/772 | Zoledronsäure Teva Pharma | Liechtenstein | 28.2.2018 |
UE/1/12/722 | Zoledronic acid Teva Pharma | Norwegia | 7.2.2018 |
UE/1/14/924 | Olysio | Islandia | 1.5.2018 |
UE/1/14/924 | Olysio | Norwegia | 1.5.2018 |
UE/1/14/985 | Raplixa | Islandia | 11.4.2018 |
UE/1/14/985 | Raplixa | Norwegia | 12.4.2018 |
UE/1/16/1107 | Zinbryta | Islandia | 25.4.2018 |
UE/1/16/1107 | Zinbryta | Liechtenstein | 30.4.2018 |
UE/1/16/1107 | Zinbryta | Norwegia | 19.4.2018 |
UE/1/17/1243 | Imatinib Teva B.V. | Islandia | 24.5.2018 |
UE/1/17/1243 | Imatinib Teva B.V. | Norwegia | 8.5.2018 |
UE/1/97/032 | LeukoScan | Islandia | 9.2.2018 |
UE/1/97/032 | LeukoScan | Liechtenstein | 28.2.2018 |
UE/1/97/032 | LeukoScan | Norwegia | 21.2.2018 |
UE/2/07/077 | Meloxivet | Islandia | 15.6.2018 |
UE/2/07/077 | Meloxivet | Liechtenstein | 30.6.2018 |
UE/2/07/077 | Meloxivet | Norwegia | 25.5.2018 |
UE/2/09/094 | BTVPUR AISap 8 | Islandia | 24.5.2018 |
UE/2/09/094 | BTVPUR AISap 8 | Norwegia | 6.6.2018 |
UE/2/10/112 | BTVPUR AISap 1 | Islandia | 24.5.2018 |
UE/2/10/112 | BTVPUR AISap 1 | Norwegia | 6.6.2018 |
UE/2/11/125 | Certifect | Islandia | 23.5.2018 |
UE/2/11/125 | CERTIFECT | Liechtenstein | 30.6.2018 |
UE/2/11/125 | CERTIFECT | Norwegia | 22.6.2018 |
ZAŁĄCZNIK V
Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
Wykaz zawieszonych pozwoleń na dopuszczenie do obrotu
Numer UE | Produkt | Państwo | Data zawieszenia |
© Unia Europejska, http://eur-lex.europa.eu/
Za autentyczne uważa się wyłącznie dokumenty Unii Europejskiej opublikowane w Dzienniku Urzędowym Unii Europejskiej.